antithrombin III
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction Identification of the ATIII Charleville as an Ala 384 Pro mutation
8
Comparative study of routine diagnostic test, C-reactive protein with antithrombin III levels in diagnosis and prognosis of neonatal sepsis
5
Identification in vitro of an endothelial cell surface cofactor for antithrombin III Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium
5
Antithrombin III (AT) and recombinant tissue plasminogen activator (R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation (DIC) in the neonatal pig
10
In vivo behavior of radioiodinated rabbit antithrombin III Demonstration of a noncirculating vascular compartment
10
Interaction of antithrombin III with bovine aortic segments Role of heparin in binding and enhanced anticoagulant activity
9
Antithrombotic properties in rabbits of heparin and heparin fragments covalently coupled to human antithrombin III
6
Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]
8
Abnormal antithrombin III with defective serine protease binding (antithrombin III "Denver")
8
Clot bound thrombin is protected from inhibition by heparin antithrombin III but is susceptible to inactivation by antithrombin III independent inhibitors
8
Inhibition of HCV by the serpin antithrombin III
10
Clearance of Thrombin from Circulation in Rabbits by High affinity Binding Sites on Endothelium: POSSIBLE ROLE IN THE INACTIVATION OF THROMBIN BY ANTITHROMBIN III
10
Antithrombin III in patients admitted to intensive care units: a multicenter observational study
5
Inherited Antithrombin III Deficiency and Cerebral Thrombosis in a Child
9
Paper reports overview: Sepsis, insulin and noninvasive ventilation
5
Identification of disease states associated with coagulopathy in trauma
9
Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response
12
Close relationship of tissue plasminogen activator plasminogen activator inhibitor 1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas
12
Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study
8
Structural Determinants of the Capacity of Heparin to Inhibit the Formation of the Human Amplification C3 Convertase
7